Northwest High School Soccer Coach, Types Of Gamefowl Gaffs, Articles S

Also, for people who cant tolerate fluvoxamine for whatever reason (nausea, jittery, etc), this is the alternative. Timing is everything with respect to outcomes. How I recommend people treat COVID and the fascinating backstory of how fluvoxamine was discovered. They left their recommendation of fluvoxamine at NEUTRAL. Steve Kirsch, current director of the Covid 19 Early Treatment fund is an MIT alumni who has made a career as a tech entrepreneur. Saving the world has been a theme of Kirschs life for years. Physicians who use the drug for COVID now swear by it. Antidepressant fluvoxamine could keep mild COVID-19 from worsening Yes, these were successes, but the successes could have been bigger if we had really paid attention to marketing. Note that some of these articles are inaccurate. While these are stunning results, less than a dozen doctors in the US are prescribing fluvoxamine today. He started a covid-19 vaccine company. Tech Entrepreneur Crusades for SSRI as COVID Therapy I've collected fluvoxamine evidence here for convenient access. Since making a fortune as the founder of Infoseek, an early search engine that was the Google of its day, Kirsch has spent tens of millions of dollars fighting humanitys biggest threats. Keyword: mit Im taking low dosage Fluvoxamine as part of a multi-drug FLCCC protocol to alleviate some mild brain fog. Fluvoxamine - The backstory T he i nsi de st ory behi nd how f l uvoxami ne became a CO V I D t herapy By Steve Kirsch Last updated: June 3, 2021 . Were having trouble saving your preferences. As of January 18, 2021, the CDC estimates that 90,000 Americans will die from COVID in just the next 3 weeks. Steve Kirsch. Get your prescription in advance of getting COVID. In June, after CETFs advisory board resigned, Kirsch did a Facebook Live video with Zelenko and celebrity rehab coach Dr. Drew. You will be wired for 24 hours if you dont heed my advice. An approach that promised to democratize design may have done the opposite. I have never heard of a case it didn't work. Infoseek lost out to Yahoo; it had a chance to grow bigger, but it didn't. How covid-19 conspiracy videos keep getting millions of views. They never make things worse so are safe to try. The reason that it isnt used is because the medical community ignores evidence-based medicine principles. Nobody who took the drug got sick at all, most all wanted to return to work within 3 days after starting treatment. I have all of these on hand and I load up on vitamin D3 every day. Hes refused to accept the results of a hydroxychloroquine trial that showed the drug had no value in treating covid, for instance, instead blaming investigators for poor study design and statistical errors. As of November 13, fluvoxamine has been proven to work in every trial that has published results, including outpatient and inpatient studies. Its not about the science. The Lancet paper showed that if you were treated early enough and took the drug as prescribed (it only works if you take it), it was shown to reduce your chance of death by 12X making it far more effective than any other drug for COVID. Delta vocus Thats what creates some of these heroes.. (PDF) Kaplan Textbook of Psychiatry JL copy - Academia.edu - Share research Compulsive hand washing? Server IP address resolved: Yes Http response code: 200 Response time: 0.27 sec. The trials that were abandoned for futility werent getting events because the patients were given standard of care meds. Generally, at 50mg BID x 14, it is very tolerable as long as the patient is instructed to lay off the caffeine. Nobody in the medical community is speaking out about how hypocritical the medical community is for ignoring the positive Phase 3 trial results and instead following whatever the NIH or FDA says. There may be a depression of libido while on drug, but since the drug is taken on acute basis, this is only temporary and it reverses once the drug is stopped. As of November 13, fluvoxamine has been proven to work in every trial that has published results, including outpatient and inpatient studies. So the drug had no chance of working (since there were no events), so the trial was stopped for futility, NOT because the drug doesnt work. These people never called the researchers whose trials they claimed showed no effect. We could have saved a lot of lives. All can merit a fluvoxamine prescription based on traditional diagnoses. But Kirsch is also motivated by an unsatisfied competitive streak. He retired at the largest pension in federal history. For example, tylenol+caffeine+fluvoxamine can lead to serotonin syndrome. One Silicon Valley entrepreneur thought he could beat the odds. The anecdotal data of 100% success rates is further icing on the cake. Note: normally I have lots of hyperlinks to all the sources, but Im pressed for time. The CDC has advised everyone to wear a mask. My favorite dosage is 50mg twice a day for 14 days. fluvoxamine The fast, easy, safe, simple, low cost treatment for COVID that has worked 100% of the time to prevent hospitalization that nobody wants to talk about We now have a viable solution to reduce COVID hospitalization and mortality; Read More fluvoxamine Got COVID? That work has yielded one promising candidate, the antidepressant fluvoxamine; other CETF-funded efforts have been less successful. Nobody who took the drug got sick at all, most all wanted to return to work within 3 days after starting treatment. It does not matter how many lives will be saved. His appearance on an episode of anti-covid-vaccine, pro-ivermectin pundit Bret Weinsteins DarkHorse podcast, alongside Robert Malone, a prominent source of vaccine misinformation, introduced Kirsch to followers of the intellectual dark web, who have since embraced him as a fellow truth-teller. In California, Silicon Valley tech entrepreneur Steve Kirsch was also thinking about the pandemic. Generally, at 50mg BID x 14, it is very tolerable as long as the patient is instructed to lay off the caffeine. The combined p value of the two studies is <.0001. This drug can save your life but you have to ask for it! But they dont want their names used. He has a history of giving away some of his millions to good causes, and when COVID-19 began. . I learned this the hard way. Hes a genuinely good guy. Thats why they didnt change their recommendation when the Phase 3 trial was published in Lancet. Less than a week later, David Seftel read about the Lenze trial, and ignored the JAMA advice. So much for evidence-based medicine. If you continue to get this message, The NIH did nothing despite the fact the that NIH, FDA, CDC, and academic institutions participated in the panel, this is NOT about the science. So it was both obvious and convincing the difference between the groups to the workers and the track management. My experience is very typical. I must admit that this is an anniversary that snuck Steve Kirsch is a high-tech serial entrepreneur based in Silicon Valley. He says that Facebook took down one of his posts announcing his appearance on 60 Minutes. The incident, he added, was completely in keeping with his personality.. In other cases, stop cold turkey. The data is there in plain sight for anyone to see today. Ive talked to doctors who are extremely familiar with the drug and all the trial results and they would prescribe it to their patients. Steve Kirsch: Vaccine Killing Millions, Treatments, VAERS, 5-Month Lack of action. I mean, he really, truly has a heart of gold, Char told me. Steve Kirsch Home page There are 4 outpatient studies that have been done (2 at WashU (see. . No more. Fluvoxamine works on hospitalized patients too, but no US hospital will let you use it (sound familiar? Keeping this drug off the NIH Guidelines does nothing to reduce the death rate. But they will refuse to give it to you even after being proven in a Phase 3 trial that was approved by the WHO. Steve calls himself a "medical philanthropist" who says "the most important thing to me is saving lives." In . Now they turn to Rust. After several failed attempts to stop the progression of his disease, he designed his own protocol for chemotherapy and doctor-shopped to find an oncologist who would give it to him. Think about it Molnupiravir has a 50% risk reduction whereas fluvxoamine is over 90%. Jeffrey Morris, director of biostatistics at the University of Pennsylvania Perelman School of Medicine, has made debunking Kirschs claims something of a hobby. Answer (1 of 2): Yes, In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of the most serious compli. Nobody in the medical community is speaking out about how hypocritical the medical community is for ignoring the positive Phase 3 trial results and instead following whatever the NIH or FDA says. O, Platelet reactivity to thrombin differs between patients with COVID-19 and those with ARDS unrelated to COVID-19 | Blood Advances | American Society of Hematology, Fluvoxamine for COVID-19 summary Steve Kirsch Executive Director COVID-19 Early Treatment Fund stk@treatearly.org 650-279-1008, Fluvoxamine for COVID-19 Steve Kirsch Executive Director COVID-19 Early Treatment Fund stk@treatearly.org 650-279-1008, Drug Repurposing Research Leads to Potentially Game-Changing Treatment to Prevent Clinical Deterioration in Outpatients With COVID, The Covid-19 Early Treatment Fund was launched to provide funding for research in order to, Steve Kirschs answer to What is the current treatment for Covid-19? Should I take ivermectin or fluvoxamine or both? - Quora If there is a better drug on the table today than fluvoxamine, the NIH panel should put that one on the guidelines. His efforts became more focused on medical research when, in 2007, he was diagnosed with a rare blood cancer. Its all about NIH saying it is OK. . In three phone conversations, as well as dozens of emails, his responses to questions about claims in this story were imprecise or constantly changing. On his blog, Covid-19 Data Science, he has extensivelyand mercilesslyunpacked Kirschs evidence for the vaccine death claims. Everyone is stunned, but nobody is surprised. The study was also featured on 60 Minutes. Dosage there is 30mg once a day. How I recommend people treat COVID and the fascinating backstory of how fluvoxamine was discovered. It is very safe: There is no evidence fluvoxamine is harmful and led to a worse outcome. Decreasing the dosage or stopping the medication will mitigate symptoms within hours. He considers himself an expert in something that he doesnt have training or experience in, and hes not following scientific methods to assess data.. They rejected the drug for insufficient evidence just like they always do for ivermectin. He's discovered a common medication that's highly effective in minimizing the impacts of COVID-19 - two studies have proven so. The ICER independent review showed fluvoxamine is more effective than Molnupiravir: Read this article I wrote about using fluvoxamine correctly for COVID. In the studies and the anecdotes I am aware of, everyone reversed symptoms within days of getting the drug. . That trial has now been completed, and the researchers are analyzing their data. Nov 12: Steve Kirsch gives talk on CETF to HarvardBusiness School hosted by Dr. Seftel Nov 13:Mass COVID outbreak at GGF is now publiclyknown Nov 16: Seftel, the track physician at GGF, startsFLV . Some countries dont have fluvoxamine so this is the alternative. Or just depression about the vaccine mandates? To protect M10 from my COVID-19 vaccination opinions, I will no longer post about my vaccination concerns here. Physicians who use the drug for COVID now swear by it. I will . This is what the Seftel trial at Golden Gate fields used. P-value was 10^-14 on that study (done by Dr. I disagree with his interpretation of the data regarding several medicines and strongly disagree with his anti-vaccine nonsense, Boulware wrote to me. The agency quickly slapped down the comments from Kirsch, a tech mogul with a fortune once estimated at $230 million, even as the claims triggered a flurry of false social-media posts attributing. At that dose, no side effects were reported for his patients (I know of only one person who had mild nausea at that dose) and everyone reversed out their symptoms in an average of 3 days. Note that some of these articles are inaccurate. The paramedics will think you are on drugs. The claim that the spike is toxic, that came directly from the [DarkHorse episode]. Medicine has been transformed to doing whatever the NIH/FDA says, regardless of how many lives will be lost. 19 In addition, several . Fluvoxamine is an inexpensive drug that has been in use for 37 years and has been used by an estimated 10 million people. . We now have a viable solution to reduce COVID hospitalization and mortality; Say you just got diagnosed with COVID. (article I did after the TOGETHER trial). These huge businesses do often prioritize profits over human health: in 2009, Pfizer paid a $2.3 billion settlement over kickbacks and fraudulent marketing, including a $1.3 billion felony fine. Doctors have no excuse for not prescribing. Flavio Cadegiani and Steve Kirsch's studies didn't make the cut. The web value rate of skirsch.io is 2 . I couldnt tell I was on the drug. Repurposed drugs are safer and more effective than the current vaccines. People are dying. Once the Phase 2 result came out, it should have been embraced by doctors. Since FLV is a safe drug, it should have been widely discussed with patients that there is virtually no downside and a huge reduction in hospitalization if the drug is given early. Most doctors wont use it until NIH greenlights it, no matter what the science says. Steve Kirsch: Don't Get the Vax! Early Treatment Saves Lives Fluvoxamine was reportedly added to just 2 practice guidelines (. Avoid caffeine, benadryl, tylenol, and alcohol. Its the gold standard of medical evidence. NIH is still unsure whether fluvoxamine should be used to treat COVID. Steve Kirsch - COVID-19 Early Treatment Fund Author Affiliations . At the beginning of the COVID-19 pandemic, Steve Kirsch created the COVID-19 Early Treatment Fund (CETF) to finance trials of off-patent drugs in an attempt to find a potent treatment that had been staring us in the face. There are other non-prescription things you should always have on hand. If the drug is started right after symptoms, weve seen 100% prevention in hospitalization. With little government funding available for such work, Kirsch founded the Covid-19 Early Treatment Fund (CETF), putting in $1 million of his own money and bringing in donations from Silicon Valley luminaries: the CETF website lists the foundations of Marc Benioff and Elon Musk as donors. But the confusion provided a fertile breeding ground for skeptics. In short, a lot of mumbo jumbo. Steve Kirsch -Executive Director at COVID-19 Early Treatment Fund Ivermection study - One .2mg/kg dose a week for prevention "100% success rate whereas those doctors taking placebo had a 59%% infection rate not a typo 237 of 400 docs on placebo got infected vs. 800 docs on Ivermectin none got infected" Antivirals Who knows, Morris replied. Doing something is better than nothing. Both drugs have compelling data that is hard to explain if the drug doesn't work. . Fluvoxamine (Luvox) is a Selective Serotonin Receptor Inhibitor (SSRI) that is clinically indicated for OCD in children, and can be used off label for depression. The choice couldn't be more clear cut. To date, we have heard nothing suggesting the drug doesn't work or could be harmful. Consider masks by contrast. All the supporting observational studies were positive as well. (The fund borrows its nonprofit status from the 501(c)(3) Rockefeller Philanthropy Advisors, which managed its money until it quit, according to the Daily Beast; neither organization is related to the Rockefeller Foundation, which supports Technology Review's reporting on covid.). The paramedics will think you are on drugs. Those days are gone. It used to be that a Phase 3 study would do it. You can help by bringing this document to your doctor's attention. And FrameMaker is still a niche product. After two weeks (since it was a tight knit community, everyone could see what was happening to the two groups), every track worker who got sick with COVID, demanded the drug. How can the FDA say a drug which meets the gold standard of evidence has insufficient evidence? Zero. Almost 2.5 million people signed up to Dr. B with the promise of getting leftover vaccines. NIH doesnt want you to get the drug since it would compete with Molnupiravir, so fluvoxamine will never make the NIH guidelines. All the researchers are convinced the drug works. Some speaker, off camera, went on a . About - vacsafety.org A very short op-ed arguing for using fluvoxamine against COVID. There were IRB rules that required the 65 patients to be listed in the diagrams and charts. Pennsylvania Senator Doug Mastriano Hosts Expert Panel on Medical For example, tylenol+caffeine+fluvoxamine can lead to serotonin syndrome. Kirsch and his group received a fresh wave of attention off hopeful trials of the antidepressant fluvoxamine, which ultimately won him a spot on 60 Minutes in March. This looks ominous, but it harmless. Vitamin D, NAC, betadine, aspirin, and Nigella sativa are all super cheap, effective, and available without a prescription. He has a BS/MS in Electrical Engineering and Computer Science from MIT. skirsch.io Steve Kirsch Home page But how many did it help? No long haul symptoms if you start the drug ASAP after first symptoms. To vet proposals, he recruited a powerhouse advisory board of prominent biologists, drug developers, and clinical researchers, led by world-renowned drug researcher Robert Siliciano of Johns Hopkins. Is fluvoxamine helpful for patients with the coronavirus? Is it - Quora Its a cycle that feeds mistrust and boosts the profiles of influencers who present themselves in opposition to official authorities. Enter the email address you signed up with and we'll email you a reset link. If you take fluvoxamine, please avoid caffeine while on the drug. Finally! Vaccine Depopulation Agenda "Confirmed"? Spike Protein Attack (The ivermectin data are trash, Feinberg told me. Doctors wait for government permission (EUA or added to the NIH guidelines) before using a drug. All this was known back in January 2021 when a key opinion leader panel of experts from NIH, CDC, FDA, academia, and journal editors voted by over 2:1 to recommend that fluvoxamine be recommended to physicians to discuss with patients. People who report not tolerating the drug are typically prescribed too high a dose. This is the gold standard of evidence based medicine, Article about the fluvoxamine rejection (The Verge). During our first conversation, which turned into a multi-hour Zoom session, Kirsch paced through the rooms of his cavernous house with his phone held at chest level, rarely looking down at the camera. By Steve Kirsch in fluvoxamine Feb 14, 2021 The case for fluvoxamine for treating COVID-19 A very short op-ed arguing for using fluvoxamine against COVID. Steve Kirsch was extremely helpful early on in the pandemic, stepping up to fund early treatment trials when the US government would not fund such studies, Boulware told me in an email. It should be crystal clear to everyone that the current CDC guidelines for treating COVID aren't working. If you start later, doctors use higher dosages and compliance becomes a bigger problem. ICER: Note that some of these articles are inaccurate. The most stunning study of fluvoxamine ever done was at the Golden Gate Fields racetrack in November 2020, right after the WashU trial was published in JAMA. Di scl ai mer: T he vi ews expressed i n t hi s art i cl e are my own personal opi ni on based on my 1, 000+ hour st udy of cut t i ng edge . This suggests that a 50mg BID loading dose for day one, followed by 50mg QD dose for the following 13 days should also be quite effective. Eventually, a press representative who was listening in, David Satterfield, unmuted his microphone to suggest we finish our conversation by email. And, according to three members of CETFs scientific advisory board, he put pressure on them to promote fluvoxamine for clinical use without conclusive data that it worked for covid. If you start 5 days after symptoms, all bets are off. . You can use fluoxetine as well (aka Prozac). Seftel used a 50mg BID dosing for 14 days which was one third of the max dose used in the Lenze study. Another is to identify an asteroid that is going to hit the planet.. Doctors who are most familiar with the drug would prescribe it to their patients. But the whole process has gone too slowly for Kirsch. Over the summer, the conflict reached his most recent startup, M10. If you ask your doctor for any evidence that fluvoxamine doesnt work or is harmful (like a DB-RCT which is the only thing they trust), they will show you nothing. 22, 2021, 9:00 a.m. Steve Kirsch , a former tech entrepreneur who earned a fortune worth up to $300 million, has been showcased on TrialSite a few times for his activity supporting the clinical development of repurposed drugs for COVID-19 treatments. National Patterns in Antidepressant Medication Treatment - Home of JAMA JAMA Reports Fluvoxamine as Potential Early Treatment for COVID-19 That is when the phase 2 results were published. Thats why they didnt even fund the fluvoxamine trial, he told me. All have had a 100% success record in keeping their patients out of the hospital. But the best way to help people is through rigorous trials that show what drugs help which people, and at what doses and timesnot by basing entire protocols on incredibly limited evidence. ). After publication of the recommendation in December 2021, the NIH did absolutely nothing change their recommendation. [https://www.quora.com/What-is-the-current-treatment-for-Covid-19/answer/, The most urgent need in the country right now is to reduce. So you can address your OCD and if you get COVID, youll can up the dose. The infectious disease scientists lied to me. Today, if we follow the CDC advice, nearly 100,000 people a month will die from COVID. The group who declined the drug were very sick with 12.5% requiring hospitalization and one died. None of this would really matter if Kirschs views on vaccinations were private, or shared with a limited audience. While he declined a phone interview, Boulware was recently the subject of a Mother Jones article about the harassment hes received for his research on hydroxychloroquine and ivermectin. Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI), a class of anti-depressants, mostly prescribed for people suffering from an obsessive-compulsive disorder. The track management was so impressed, they asked for prescriptions. Timing is everything with respect to outcomes. Here's why. Those who know Kirsch say this is a typical tactic. While Fauci was crafting national pandemic policies, Fauci's wife [Christine Grady, Chief Bioethicist, NIH] was back stopping [them]." Report coming soon. 'In every single case, treat virus early and treat it hard': Steve Kirsch NIH and WHO refuse to acknowledge it works since it will cause vaccine hesitancy if it is known that there is a drug that turns COVID into a mild disease. So when a group of scientists applied for an EUA for fluvoxamine, what did the FDA do? He has been a medical philanthropist for more than 20 years. The findings, published Wednesday in the New England Journal of Medicine, add to a growing body of scientific evidence pushing back against the use of the antiparasitic drug that has been promoted by some prominent voices on social media. Silence from the medical community. Steve Kirsch is a high-tech serial entrepreneur based in Silicon Valley. To scientists, giving fluvoxamine a chance means running a large trialnot giving it to individual patients in the clinic, off-label and outside the context of active data collection and analysis. Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI), a class of anti-depressants, mostly prescribed for people suffering from an obsessive-compulsive disorder. In it, he claimed mRNA vaccines kill one in 5,000 recipients and dramatically increase the rate of miscarriages. 533. Boulware disputes that, and says that although Kirschs funding was important, his statements about drugs and vaccines have proven problematic. Design thinking was supposed to fix the world. That receptor also helps regulate the body's . . Perhaps Kirschs most effective tactic, though, is simply his willingness to outlast everyone else. . Every earlier study of fluvoxamine (such as observational studies) showed it work and the mechanism had been shown. They all promised me when fluvoxamine passed Phase 3 trials, nearly everyone would use it. This is the gold standard of evidence based medicine. Another CETF grant, though, yielded far more exciting results. NIH is still unsure whether fluvoxamine should be used to treat COVID (article I did after the TOGETHER trial). Its whether Merck can make a killing that matters. On January 22, 2021, thirty key opinion leaders (KOL) from NIH, CDC, and leading academic institutions met to review the evidence for using fluvoxamine for treating COVID. This was shown to be very tolerable (no side effects in 99% of patients) and extremely effective (no hospitalizations and death if you start it ASAP after first symptoms). Silicon Valley entrepreneur Steve Kirsch urges the FDA to quickly Items included in the Television News search service. For decades, coders wrote critical systems in C and C++. Hilary Grant-Valdez Operations Manager Tom Brunner The medical community did nothing (with a few exceptions like Dr. Seftel). I fully expected both organizations to do absolutely nothing. Fluvoxamine for COVID-19 summary Steve Kirsch Executive Director COVID-19 Early Treatment Fund stk@treatearly.org 650-279-1008 Google Docs This is a more comprehensive look at the key evidence supporting fluvoxamine: Fluvoxamine for COVID-19 It was recommended back in January 2021 by a key opinion leader (KOL) panel to be used, but it took a year for the KOL meeting notes to be published because they were rejected by 10 journals.